Gastric cancer among peptic ulcer patients: Retrospective, long-term follow-up

Digestive and Liver Disease

Volumn 38, Issue 11, 2006, Pages 811-814

  Ogura, M ^a,b   Yamaji, Y ^b   Hikiba, Y ^a   Maeda, S ^a   Matsumura, M ^a   Okano, K ^a   Sassa, R ^a   Yoshida, H ^b   Kawabe, T ^b   Omata, M ^b  

^a INSTITUTE FOR ADULT DISEASES   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Duodenal ulcer; Endoscopy; Gastric cancer; Gastric ulcer; Long term follow up

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

ABDOMINAL SURGERY; ADULT; AGE; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; DUODENUM ULCER; FEMALE; FOLLOW UP; GENDER; HUMAN; KAPLAN MEIER METHOD; LOG RANK TEST; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH ULCER;

DUODENAL ULCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; JAPAN; KAPLAN-MEIER ESTIMATE; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STOMACH NEOPLASMS; STOMACH ULCER;

EID: 33748927479     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2006.07.004     Document Type: Article

References (19)

1. Infection with Helicobacter pylori. In: IARC monographs on the evaluation of the carcinogenic risks to humans. Schistosomes, liver flukes and Helicobacter pylori, vol. 61. Lyon, France: International Agency for Research on Cancer; 1994. p. 177-241
2. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 49 (2001) 347-353 [review]
3. Uemura N., Okamoto S., Yamamoto S., Matsumura N., Yamaguchi S., Yamakido M., et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345 (2001) 784-789
4. Hopkins R.J., Girardi L.S., and Turney E.A. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 110 (1996) 1244-1252 [review]
5. Rosenstock S., Jorgensen T., Bonnevie O., and Andersen L. Risk factors for peptic ulcer disease: a population based prospective cohort study comprising 2416 Danish adults. Gut 52 (2003) 186-193
6. Hansson L.E., Nyren O., Hsing A.W., Bergstrom R., Josefsson S., Chow W.H., et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 335 (1996) 242-249
7. Asaka M., Takeda H., Sugiyama T., and Kato M. What role does Helicobacter pylori play in gastric cancer?. Gastroenterology 113 (1997) S56-S60 [review]
8. Nardone G. Risk factors for cancer development in Helicobacter pylori gastritis. Dig Liver Dis 32 (2000) S190-S192
9. Whiting J.L., Sigurdsson A., Rowlands D.C., Hallissey M.T., and Fielding J.W. The long term results of endoscopic surveillance of premalignant gastric lesions. Gut 50 (2002) 378-381
10. Take S., Mizuno M., Ishiki K., Nagahara Y., Yoshida T., Yokota K., et al. The effect of eradicating Helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease. Am J Gastroenterol 100 (2005) 1037-1042
11. Sugiyama T., Nishikawa K., Komatsu Y., Ishizuka J., Mizushima T., Kumagai A., et al. Attributable risk of H. pylori in peptic ulcer disease: does declining prevalence of infection in general population explain increasing frequency of non-H. pylori ulcers?. Dig Dis Sci 46 (2001) 307-310
12. Furuta T., El-Omar E.M., Xiao F., Shirai N., Takashima M., and Sugimura H. Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 123 (2002) 92-105
13. The Research Group for Population-based Cancer Registration in Japan. Cancer incidence in Japan, 1985-89: re-estimation based on data from eight population-based cancer registries. Jpn J Clin Oncol 28 (1998) 54-67
14. Gillen D., El-Omar E.M., Wirz A.A., Ardill J.E., and McColl K.E. The acid response to gastrin distinguishes duodenal ulcer patients from Helicobacter pylori-infected healthy subjects. Gastroenterology 114 (1998) 50-57
15. El-Omar E.M., Oien K., El-Nujumi A., Gillen D., Wirz A., Dahill S., et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 113 (1997) 15-24
16. Leung W.K., Lin S.R., Ching J.Y., To K.F., Ng E.K., Chan F.K., et al. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut 53 (2004) 1244-1249
17. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 52 (1992) 6735-6740 [review]
18. Kokkola A., Haapiainen R., Laxen F., Puolakkainen P., Kivilaakso E., Virtamo J., et al. Risk of gastric carcinoma in patients with mucosal dysplasia associated with atrophic gastritis: a follow up study. J Clin Pathol 49 (1996) 979-984
19. Watabe H., Mitsushima T., Yamaji Y., Okamoto M., Wada R., Kokubo T., et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut 54 (2005) 764-768